BIOPORTUGAL S.A. secures contract for Reagents and contrast media - ACQUISITION OF REAGENTS TO IMPLEMENT THE NEXT GENERATION SEQUENCING NGS 2026 METHODOLOGY

Portugal, May 8 -- Portugal based BIOPORTUGAL S.A. has secured contract from Unidade Local de Saude de Almada-Seixal, EPE for Reagents and contrast media - ACQUISITION OF REAGENTS TO IMPLEMENT THE NEXT GENERATION SEQUENCING NGS 2026 METHODOLOGY. The value of the contract is worth 52353000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....